In the fourth episode of the IQVIA-sponsored PSCS leadership video series, Zoltan Varga discusses the importance of understanding patient motivations
GSK is said to be preparing to cut around 1,200 positions from its workforce in Belgium as part of a cost-saving programme launched by CEO Luke Miels.
While the volume of announcements hit a mid-year slump, July and August still produced an exciting array of updates across the drug development arena.
Zealand has added another strand to its programme of weight-loss drug development, linking with AI player Generate on multispecific protein therapies.
BioNTech's vaccine for head and neck cancer has failed a clinical trial, but it will wait for more data before deciding the programme's fate.
Editor's Picks
